Browse News
Filter News
Found 518,405 articles
-
AstraZeneca and its MedImmune division released data on overall survival (OS) in its Phase III PACIFIC clinical trial of Imfinzi (durvalumab).
-
Swiss pharmaceutical giant Novartis plans to slash approximately 2,200 jobs in Switzerland over the next four years.
-
This morning, Genentech released results of its Phase III IMpower 133 trial that showed treatment with Tecentriq plus chemotherapy helped people with extensive-stage small cell lung cancer live significantly longer than with chemotherapy alone.
-
Verastem Gets FDA Approval for Leukemia Drug, Will Make It Immediately Available to Patients
9/25/2018
Shares of Verastem closed out Monday trading on a positive note and continues to climb in the premarket following the greenlight for leukemia drug Copiktra, an inhibitor of phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma. -
A commercially-available medical device developed by Medtronic is helping paralyzed patients walk again.The device, which stimulates the spinal cord through electrical pulses, has been successful in helping some individuals who lost the ability to walk through injuries to their spine, regain the ...
-
Tesaro Highlights Benefits of Maintenance Therapy Zejula During Ovarian Cancer Awareness Month
9/25/2018
Ovarian cancer is the fifth leading cause of cancer-related deaths in the United States. It is estimated that this year there will be more than 22,000 women in the U.S. diagnosed with the disease and about 14,000 disease-related deaths. -
Biotechnology company Morphic Therapeutic has just publicized their completion of a successful $80 million Series B financing meant to support their two lead programs in developing modern oral integrin therapies, as well as further other clinic programs.
-
Pharma Companies React to Employers and Health Plans Excluding New Therapies Based on Cost
9/25/2018
Recently, a few companies and government programs have decided to enact their own plans that they believe will help bring down the cost of new therapies. Pharmaceutical companies have begun asserting their positions on the topic. -
As the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical edges forward, yet another major Takeda shareholder has spoken out in opposition to the deal.
-
Are you ready to look for a new job? If you have made the decision to put yourself on the job market, there are a few things that you need to do right away to get yourself ready for the process… and it is a process.
-
BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2018 Awards Gala
9/25/2018
At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.
-
BLINCYTO® (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia
9/25/2018
First Approved Oncology Treatment From Amgen Astellas Joint Venture
-
Minomic Announces Completion of Demerger of GlyTherix Ltd
9/25/2018
Demerger clears the path for therapeutic company capital raising
-
Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal
9/25/2018
Med-X, Inc.'s green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation's leading green-focused pest control service companies, Pestmaster Services.
-
CathWorks FFRangio™ Trial Meets Primary Endpoint and Exceeds Performance Goals
9/25/2018
Trial Results Published in Circulation
-
Andalou Naturals Celebrates Non-GMO Month with the First Hemp Inspired Beauty Collection to Achieve Non-GMO Project Verified Status
9/25/2018
Andalou Naturals, the Novato-based leader in natural luxury beauty, launched CannaCell®, the first hemp-based beauty collection to receive Non-GMO Project Verified status.
-
Elanco Animal Health Expands Commitment to Fight Antimicrobial Resistance
9/25/2018
Elanco Animal Health (NYSE: ELAN) today updated its commitment to fighting antimicrobial resistance, which includes promoting responsible antibiotic use practices and policies while developing alternatives to medically important antibiotics (a subset of which include critically important antibiotics to human health).
-
Health Officials Respond to Alarming Increases in Congenital Syphilis
9/25/2018
Newborn syphilis cases have more than doubled in the last 4 years, and last year, the United States saw the most cases of congenital syphilis since 1997, according to a new CDC report.
-
EOS imaging to Showcase the EOS Solution at the 2018 North American Spine Society (NASS) Annual Meeting September 26-29, 2018 in Los Angeles
9/25/2018
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, will present the EOS imaging offering with a focus on its spineEOS 3D surgical planning software during the 33rd Annual Meeting of the North American Spine Society (NASS).
-
Bringing Light To The Darkness Of Cancer: The Leukemia & Lymphoma Society's Powerful Partners Are Saving Lives
9/25/2018
As The Leukemia & Lymphoma Society's (LLS) Light The Night fundraising campaign continues to beat growth records, leading national companies and brands are signing on to help light the path to cancer cures and give hope to cancer patients nationwide